BlackRock Inc. Acquires 1,039,442 Shares of Oak Street Health, Inc. (NYSE:OSH)

BlackRock Inc. lifted its holdings in shares of Oak Street Health, Inc. (NYSE:OSH) by 27.2% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,860,912 shares of the company’s stock after acquiring an additional 1,039,442 shares during the quarter. BlackRock Inc.’s holdings in Oak Street Health were worth $263,803,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of OSH. Fifth Third Bancorp bought a new stake in Oak Street Health in the 1st quarter valued at $55,000. American International Group Inc. boosted its stake in Oak Street Health by 255.1% in the 1st quarter. American International Group Inc. now owns 1,580 shares of the company’s stock valued at $86,000 after purchasing an additional 1,135 shares during the period. Arkadios Wealth Advisors bought a new stake in Oak Street Health in the 4th quarter valued at $121,000. Raymond James Financial Services Advisors Inc. bought a new stake in Oak Street Health in the 4th quarter valued at $217,000. Finally, Handelsbanken Fonder AB bought a new stake in Oak Street Health in the 1st quarter valued at $217,000. Institutional investors own 77.87% of the company’s stock.

In other Oak Street Health news, COO Geoffrey M. Price sold 25,000 shares of the company’s stock in a transaction dated Tuesday, June 8th. The stock was sold at an average price of $58.91, for a total value of $1,472,750.00. Following the completion of the transaction, the chief operating officer now owns 3,817,389 shares of the company’s stock, valued at approximately $224,882,385.99. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Robert Guenthner sold 5,902 shares of the company’s stock in a transaction dated Thursday, June 3rd. The stock was sold at an average price of $59.91, for a total value of $353,588.82. Following the completion of the transaction, the insider now directly owns 525,918 shares of the company’s stock, valued at approximately $31,507,747.38. The disclosure for this sale can be found here. Insiders have sold a total of 7,892,163 shares of company stock valued at $474,333,810 in the last three months. 10.10% of the stock is owned by insiders.

Oak Street Health stock opened at $57.67 on Friday. The company has a debt-to-equity ratio of 3.23, a current ratio of 4.11 and a quick ratio of 4.11. Oak Street Health, Inc. has a 52 week low of $37.11 and a 52 week high of $66.31. The firm has a market cap of $13.89 billion and a PE ratio of -0.79. The stock’s fifty day simple moving average is $59.84.

Oak Street Health (NYSE:OSH) last posted its quarterly earnings results on Monday, May 10th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.06). Oak Street Health had a negative return on equity of 60.50% and a negative net margin of 24.18%. The business had revenue of $296.70 million for the quarter, compared to analyst estimates of $283.40 million. Oak Street Health’s quarterly revenue was up 47.0% on a year-over-year basis. As a group, research analysts anticipate that Oak Street Health, Inc. will post -1.58 earnings per share for the current year.

Several analysts recently issued reports on OSH shares. Cantor Fitzgerald started coverage on Oak Street Health in a research note on Tuesday, April 20th. They issued an “overweight” rating and a $75.00 price target for the company. Morgan Stanley boosted their price target on Oak Street Health from $73.00 to $79.00 and gave the company an “overweight” rating in a research note on Friday, March 12th. Zacks Investment Research upgraded Oak Street Health from a “sell” rating to a “hold” rating in a research note on Tuesday, May 18th. Canaccord Genuity began coverage on Oak Street Health in a research report on Wednesday, February 24th. They set a “buy” rating and a $67.00 target price for the company. Finally, Sanford C. Bernstein began coverage on Oak Street Health in a research report on Friday, May 21st. They set an “outperform” rating and a $79.00 target price for the company. Two equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Oak Street Health has a consensus rating of “Buy” and an average target price of $68.36.

Oak Street Health Company Profile

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2020, it operated 79 centers in Illinois, Indiana, Michigan, Mississippi, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, Tennessee, and Texas.

Read More: What is a balanced fund?

Want to see what other hedge funds are holding OSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oak Street Health, Inc. (NYSE:OSH).

Institutional Ownership by Quarter for Oak Street Health (NYSE:OSH)

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.